Trial Profile
A Phase II, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3384 in Patients With Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Mar 2024
Price :
$35
*
At a glance
- Drugs Colestyramine (Primary)
- Indications Primary bile acid malabsorption
- Focus Therapeutic Use
- Acronyms A3384 in BAM/BAD
- Sponsors Albireo AB
- 12 Oct 2016 Status changed from recruiting to completed.
- 13 Mar 2014 New trial record